Skip to content

Application of electroacupuncture combined with erector spinae plane block in anesthesia of non tracheal intubation thoracoscopic surgery

Application of electroacupuncture combined with erector spinae plane block in anesthesia of non tracheal intubation thoracoscopic surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003773
Enrollment
Unknown
Registered
2020-08-27
Start date
2020-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracoscopic lobectomy

Interventions

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) The ASA grade was I - III; 2) Aged 18-65 years, no gender limit; 3) Patients without previous immune system diseases; 4) Sign informed consent.

Exclusion criteria

Exclusion criteria: Study one exclusion criteria 1) Patients who have participated in other clinical trials in the past four weeks; 2) Patients who could not cooperate to complete the study included infectious diseases and other medical history; 3) Patients with positive urine pregnancy test; 4) Patients with preoperative pain, using central analgesics, opioid addicts and addicts; 5) Severe other system diseases and serious mental diseases were found before operation; 6) Patients with abnormal liver and kidney function (ALT, AST, BUN, Cr exceeding 1.5 times of normal value); 7) BMI>=30kg/m2 or Weight less than 50kg; 8) Organic heart disease or arrhythmia; 9) Emergency surgery or video-assisted thoracoscopic surgery; 10) Spinal deformity, abnormal blood coagulation, and infection of puncture site of erector spinalis plane block. Study 2 exclusion criteria 1) Patients with skin infection at acupoints and limb nerve injury; 2) Patients who have participated in other clinical trials in the past four weeks; 3) Patients who could not cooperate to complete the study included infectious diseases and other medical history; 4) Patients with positive urine pregnancy test; 5) Patients with preoperative pain, using central analgesics, opioid addicts and addicts; 6) Severe other system diseases and serious mental diseases were found before operation; 7) Patients with abnormal liver and kidney function (ALT, AST, BUN, Cr exceeding 1.5 times of normal value); 8) BMI>=30kg/m2 or Weight less than 50kg; 9) Organic heart disease or arrhythmia; 10) Emergency surgery or video-assisted thoracoscopic surgery; 11) Spinal deformity, abnormal blood coagulation, and infection of puncture site of erector spinalis plane block.

Design outcomes

Primary

MeasureTime frame
Intraoperative remifentanil dosage;Does the patient have agitation when extubation tracheal tube;Changes of vital signs at the beginning of skin incision;Whether or not to use remedial analgesics 2 hours after operation and VAS score;

Secondary

MeasureTime frame
The highest value of partial pressure of carbon dioxide in blood gas analysis during operation;The changes of blood indexes such as plasma cortisol, pain mediators ß - endorphin, 5-hydroxytryptamine, inflammatory mediators IL-6 and TNF - a before and after operation;Time of spontaneous respiration recovery after anesthesia induction;Intraoperative remifentanil dosage;

Countries

China

Contacts

Public ContactHaifeng Shi

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Medicine

215756265@qq.com+86 18721752280

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026